“Katakwi district is one of the slow growing in Uganda and poor service delivery is one of the reasons. Now, this background has led to the fast spread of Hepatitis B in this Eastern district which according to locals and their leaders steals more than 5 lives every month” (NTV Uganda, 2016)
So if either Dr. Jennifer Musisi have any answers? Do Hon. Frank Tumwebaze any wise words to the world? Lastly does the new guy Presidential Advisor for Kampala Affairs Singh Katongole any words to utter? I don’t expect wisdom from Lord Mayor Erias Lukwago since Musisi and Tumwebaze impeached him and during the period you guys have run the place. Do you have any wisdom, If you have feel free to comment on the blog and drop the wisdom on the matter; as the leadership are on your shoulders. Please do and comment as the Vaccine have been delivered and then went into thin air… Peace.
KAMPALA, March 14: “In God we trust, all others bring data,” a quote attributed to American professor and statistician William Edwards Deming, is widely used to underscore the role accurate data play in building credibility.
As a result of the lack of verified, up-to-date data, a report released ahead of the ministerial conference on immunisation in Africa last month ranked Uganda’s routine immunisation coverage as among the lowest in the East African sub-region.
The report which tracks immunisation progress and challenges across the continent since the Global Vaccine Action Plan (GVAP) was launched and entitled, “Fulfilling a promise: Ensuring immunisation for all in Africa”, rates Uganda’s 2014 diptheria-tetanus-pertussis (DTP3) coverage at 78 per cent compared with 80 per cent for the Democratic Republic of Congo (DRC), 81 per cent Kenya, 97 per cent for Tanzania and 99 per cent for Rwanda.
Coverage with the third dose of DTP is used to measure the strength and reach of a country’s routine immunisation programme.
The DTP3 target for countries was 90 per cent for national coverage by 2015 or at least 80 per cent coverage in every district. Experts recommend that children receive DTP three times at appropriate intervals.
Conakry, 25 March, 2015 – The Guinean Government with the World Health Organization (WHO) initiated the very first efficacy trial of an Ebola vaccine this week in an affected community of the Basse-Guinée, one of the areas where most Ebola cases are found in the country. Ring vaccination tests of VSV-EBOV, a lead Ebola vaccine developed by the Public Health Agency of Canada, received an excellent response from the community in a small village in the Coyah prefecture, where the trial team arrived on 23 March.
“This landmark operation gives hope to all of us, in Guinea and in the world, that we might soon have an effective public health tool against Ebola, should the vaccine prove to be safe and effective,” stated the WHO Representative in Guinea, Dr. Jean-Marie Dangou. “The start of ring vaccination clinical testing today in Guinea is therefore one of the most important milestones we have achieved in seeking a modern line of defense against Ebola.”
Trained medical staff, vaccines and other essential equipment were dispatched from Conakry to Coyah to vaccinate contacts of recently infected people who have given consent in a village of the Coyah prefecture. Vaccinations for now will include only adults, who are most at risk of infection, with the exception of pregnant women.
“We are committed to ending this epidemic,” said Dr. Sakoba Keita, National Coordinator of the Fight against Ebola in Guinea. “Combined with control measures that we are putting in place with our partners, a safe and effective vaccine will allow us to close this trying chapter and start rebuilding our country.”
The ring vaccination strategy consists in identifying recently infected patients and vaccinating all their contacts, thereby creating a ‘ring of immunity’ around them to stop the virus from spreading.
“This very same strategy was a key contribution to eradicating smallpox in the 1970’s, and allows us to vaccinate all those at greatest risk,” explained WHO Coordinator for the Guinea Vaccine Trial, Dr. Ana Maria Henao Restrepo.
Dr. Bertrand Draguez, Medical Director for the Non-governmental Organization Médecins sans Frontières (MSF) stressed that: “The trial is organized on a voluntary basis, and participation is confidential, free and non-remunerated.”
The Guinean Government is fully committed to the success of the vaccine clinical trial. In a 20 March official letter addressed to all the Mayors, Prefects and local Health Officials in Guinea, the Head of the National Coordination Against Ebola in Guinea, Dr Sakoba Keita, asked all local public actors for their full cooperation and support.
A total of around 10 000 people are planned to be vaccinated in 190 rings within a six-eight week period. Volunteers will be followed for three months. Results could be available as early as July 2015.
Note to editors
About the vaccine and the vaccination strategy:
VSV-EBOV Vaccine was developed by the Public Health Agency of Canada. The vaccine was licensed to NewLink Genetics, and on November 24, 2014, NewLink Genetics and Merck announced their collaboration on the vaccine.
The concept of ring vaccination applied to the Guinea Ebola vaccine clinical trial is based on vaccinating the “rings” (group of contacts of a newly diagnosed Ebola “index case”) either immediately after confirmation of the Ebola diagnosis of the “index case”, or three weeks later (delayed vaccination). This strategy allows all the known contacts to be vaccinated within a short period of time, and it constitutes an excellent alternative to the use of a placebo. The ring vaccination trial design was developed by an international group of experts from Canada, France, Guinea, Norway, Switzerland, United Kingdom, United States, and WHO. This group included Professor Donald A. Henderson, who led the WHO smallpox eradication effort.
The Guinea Ebola vaccine trial is a coordinated effort among numerous international partners. The trial is implemented under the responsibility of the Guinean government. The World Health Organization (WHO) is the sponsor of the study. The Government of Guinea, Doctors without Borders / Medecins sans Frontières (MSF), Epicentre, the Norwegian Institute of Public Health and WHO are coordinating its implementation. The trial is funded by MSF; the Research Council of Norway through the Norwegian Institute of Public Health; the Canadian government through the Public Health Agency of Canada, Canadian Institutes of Health Research, International Development Research Centre and Department of Foreign Affairs, Trade and Development; and WHO, with support from the Wellcome Trust, United Kingdom.
For more information, please contact:
Pr Jean-Marie DANGOU, WHO Representative to Guinea
Cel : + 224 623 23 55 55
Dr Ana Maria Henao Restrepo
E-mail : firstname.lastname@example.org
M. Konaté Issiaga
Tel : +224 62 59 70 42
E-mail : email@example.com
Tel : +224 624 827 240
Email : firstname.lastname@example.org
Tel : +224 624 827 337
Tel : +224 624 827 350
This Ebola disease has taken its toll and that why I have made this blog post. With various sources quoting in the recent week on the matter, to prove what the nations does and don’t. Also too show the progress of multilateral organizational co-ops in the affected countries in the West Africa.
This is what the US Government entities have to say about people with Ebola reaching its shores;
“Today, as part of the Department of Homeland Security’s ongoing response to prevent the spread of Ebola to the United States, we are announcing travel restrictions in the form of additional screening and protective measures at our ports of entry for travelers from the three West African Ebola-affected countries. These new measures will go into effect tomorrow (…) Today, I am announcing that all passengers arriving in the United States whose travel originates in Liberia, Sierra Leone or Guinea will be required to fly into one of the five airports that have the enhanced screening and additional resources in place (…) We currently have in place measures to identify and screen anyone at all land, sea and air ports of entry into the United States who we have reason to believe has been present in Liberia, Sierra Leone or Guinea in the preceding 21 days” (DHS Press Office, 21.10.2014).
“The Centers for Disease Control and Prevention (CDC) announced that public health authorities will begin active post-arrival monitoring of travelers whose travel originates in Liberia, Sierra Leone, or Guinea. These travelers are now arriving to the United States at one of five airports where entry screening is being conducted by Customs and Border Protection and CDC. Active post-arrival monitoring means that travelers without febrile illness or symptoms consistent with Ebola will be followed up daily by state and local health departments for 21 days from the date of their departure from West Africa” (CDCP, 22.10.2014).
Multilateral organizational response to health issues recently:
IMF addresses first: “The strong growth trends of recent years in the sub-Saharan Africa region are expected to continue. The region’s economy is forecast to continue growing at a fast clip, expanding by about 5 percent in 2014, the same level as in 2013, and accelerating to around 5¾ percent in 2015, underpinned by continued public investment in infrastructure, buoyant services sectors, and strong agricultural production. This growth momentum is particularly pronounced in the region’s Low-Income Countries, where activity is forecast to accelerate to 6¾-7 percent in 2014-15” (…)”This positive picture, however, co-exists with the dire situation in Guinea, Liberia, and Sierra Leone, where, beyond the unbearable number of deaths, suffering, and social dislocation, the Ebola outbreak is exacting a heavy economic toll, with economic spillovers starting to materialize in some neighboring countries” (…)”In the countries currently affected by the Ebola outbreak, fiscal accounts are coming under considerable pressure. Ideally, support should be provided through grants from the donor community, to enable the countries to accommodate higher Ebola-related spending and to help avoid an even more pronounced decline in economic activity. However, when grants are not immediately forthcoming, and provided that the public debt levels remain manageable, fiscal deficits should be allowed to widen, subject to the availability of financing” (IMF, 20.10.2014)
Tostan addresses secondly: “Guinea has been confronted with the serious Ebola epidemic which, due to the surprising apparition of the disease and the unpreparedness of health authorities, has taken the lives of an unprecedented number of families and health workers. Despite preventative measures taken by Guinean authorities with the support of development partners, Ebola persists in the country” (…)”Using our approach of organized diffusion, 17 Tostan supervisors will hold educational discussions in local languages to raise awareness on the Ebola virus. 2,784 community members from 116 Community Management Committees (CMCs) and the Local Council for Children and Families (CLEF – in French) will educate their relatives, friends, and at least three districts and neighboring villages” (…)”Other preventative measures include the distribution and installation of hand-washing kits in each Tostan office in Conakry, Labe, and Faranah by the National Coordination of Tostan Guinea. The Governor and Prefect of Faranah, who visited the regional Tostan office, congratulated Tostan for putting in safety measures to help prevent the spread of Ebola amongst the staff and the 116 partner communities, as well as acknowledging the hundreds of other adopted communities reached through organized diffusion” (Tostan, 20.10.2014).
UNFPA addresses it as a third: “The United Nations Population Fund (UNFPA) today reaffirmed its commitment to a partnership with Amref Health Africa aimed at improving the health of women and children in Africa. Speaking at the exchange of a signed Memorandum of Understanding that makes Amref Health Africa an implementing partner for UNFPA in Africa, Dr Laura Laski, Chief of Sexual and Reproductive Health at UNFPA, said the partnership intended to strengthen health systems by training midwives to building their capacity to respond to health issues, particularly those related to maternal, neonatal and adolescent health” (…)”She emphasised that high maternal mortality in Africa is an unfinished agenda of the Millennium Development Goals, and one of the critical issues that will be discussed at the Amref Health Africa International Conference to be held in Nairobi from November 24-26. She urged African governments to increase their commitment and contribution to health development, as well as individuals, corporates and institutions” (UNFPA, 23.10.2014).
WHO addresses is a fourth: “WHO convened a meeting with high-ranking government representatives from Ebola-affected countries and development partners, civil society, regulatory agencies, vaccine manufacturers and funding agencies yesterday to discuss and agree on how to fast track testing and deployment of vaccines in sufficient numbers to impact the Ebola epidemic” (…)”Results from phase 1 clinical trials of most advanced vaccines are expected to be available in December 2014 and efficacy trials in affected countries also will begin in this timeframe, with protocols adapted to take into consideration safety and immunogenicity results as they become available” (…)”Pharmaceutical companies developing the vaccines committed to ramp up production capacity for millions of doses to be available in 2015, with several hundred thousand ready before the end of the first half of the year” (…)”Community engagement is key and work should be scaled up urgently in partnership between local communities, national governments, NGOs and international organizations” (WHO, 24.10.2014).
African Development Bank group together with a collective or affiliates is the five one to address it: “Leaders of three Pan-African institutions – the African Union Commission’s Dr Nkosazana Dlamini Zuma, the African Development Bank’s Dr Donald Kaberuka, and the United Nations Economic Commission for Africa’s Dr. Carlos Lopes – concluded a solidarity tour on Friday 24 October 2014 in Conakry, Guinea” (…) ”They met with Heads of Government, cabinet Ministers, parliamentarians, civil society and media in the affected countries, as well as with leaders of two neighbouring countries, Ghana and Côte d’Ivoire. Ghana also hosted the delegation in its capacity as the current President of the Economic Community of West African States (ECOWAS)” (…)”They recognised the stepped up contributions of the international community in providing financial, technical, infrastructural and medical support to the fight against the EVD, and urged all to do still more” (…)”the AfDB’s contribution – currently at over 220 million USD – includes supporting the international response, budgetary support for the deployment of health workers from across Africa and the diaspora, as well as supporting the health systems in the three countries, including training local health extension and community workers” (…)”It felt that the virus – and perceptions about it – cannot be allowed to affect the economic prospects of the fastest growing continent. The group strongly believed that the Mano River Basin countries, now at the epicenter of the epidemic, continue to have some of the best economic prospects of the continent. In continuing to call for a lifting of all travel bans, it was pleased to hear that Côte d’Ivoire has resumed flights to Guinea this week, and will do so with Sierra Leone and Liberia in the coming days” (ADBG, 25.10.2014).
RMS Stats on Ebola:
I think this is all for today! Peace.
African Development Bank Group: ‘AUC, AfDB and ECA confident that countries will beat Ebola Virus Disease’ (25.10.2014) Link: http://www.afdb.org/en/news-and-events/article/auc-afdb-and-eca-confident-that-countries-will-beat-ebola-virus-disease-13667/
Centers for Diseases Control and Prevention (CDCP): ‘CDC Announces Active Post-Arrival Monitoring for Travelers from Impacted Countries’ (22.10.2014) Link: http://www.cdc.gov/media/releases/2014/p1022-post-arrival-monitoring.html
DHS Press Office: ‘Statement by Secretary Johnson on Travel Restrictions and Protective Measures to Prevent the Spread of Ebola to the United States’ (21.10.2014) Link: http://www.dhs.gov/news/2014/10/21/statement-secretary-johnson-travel-restrictions-and-protective-measures-prevent
IMF: ‘IMF Projects Robust Growth in Sub-Saharan Africa, Amid Shifting Global Forces’ (20.10.2014) Link: http://www.imf.org/external/np/sec/pr/2014/pr14475.htm
TOSTAN: ‘Tostan involved in awareness raising activities on Ebola in Guinea’ (20.10.2014) Link: http://www.tostan.org/news/press-release-tostan-involved-awareness-raising-activities-ebola-guinea
UNFPA: ‘UNFPA and Amref Health Africa seal Partnership to Boost the Health of Africa’s Women and Children’ (23.10.2014) Link: http://www.pressreleasepoint.com/unfpa-and-amref-health-africa-seal-partnership-boost-health-africa-s-women-and-children
WHO: ‘WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine’ (24.10.2015) Link: http://www.who.int/mediacentre/news/releases/2014/ebola-vaccines-production/en/
RMS: ‘RMS Develops World’s First Probabilistic Model of West African Ebola Outbreak, Finds Current Outbreak Has Potential to be Deadliest Infectious Disease Event in a Century’ (23.10.2014) Link :http://www.rms.com/about/newsroom/press-releases/press-detail/2014-10-23/rms-develops-worlds-first-probabilistic-model-of-west-african-ebola-outbreak-finds-current-outbreak-has-potential-to-be-deadliest-infectious-disease-event-in-a-century